KRT18 and metabolic dysfunction-associated steatohepatitis: Previous efforts have commonly measured individual (or a few) inflammatory mediators in NASH-patients (5, 11–14), including cytokeratin (CK)-18, probably the most evaluated biomarker of NASH (15, 16).